The impact of INH-alpha (rs12720062 G/A) gene polymorphism and serum vitamin D level on risk of premature ovarian failure
Main Article Content
Keywords
Premature ovarian failure, vitamin D, INH-alpha
Abstract
Background: The loss of ovarian function before the age of 40 is referred to as premature ovarian failure (POF). Genetic conditions and some acquired conditions may be to blame for premature ovarian failure. Vitamin D deficiency has been linked to a number of medical conditions and recent data suggest a link between premature ovarian failure and this deficiency; however, clear consensus among authors does not exist. Genetic wise, a link between premature ovarian failure and INH-alpha (rs12720062 G/A) gene polymorphism is shown by some authors.
Aim of the study: To investigate the impact of inhibin alpha gene polymorphism and serum vitamin D level to risk of premature ovarian failure.
Patients and methods: The study included forty women with signs and symptoms of POF and forty fertile and healthy women to represent the control group. Patients and control individuals were collected from three fertility units in Iraq, Um-Albaneen fertility center in Al-Imamain Al-Kadhimain Madical City - Baghdad, Higher Institute of Infertility Diagnosis and Assisted Reproductive
Techniques - Baghdad, and from the infertility unit in Women’s and children’s hospital at Al-Diwaniyah city. Samples collection was performed during the period extended from August 2021 to September 2022. Serum vitamin D level was measured by finecare and serum inhibin was measured by ELISA. Genetic study of INH-alpha (rs12720062 G/A) genotypes and alleles was done.
Results: Average vitamin D serum level of POF category was lower significantly than that of control group, 15.17 ±3.82 ng/ml versus 40.68 ±5.76 ng/ml, respectively (p < 0.001). In addition, mean Inhibin-Alpha of POF was significantly lower than that of group of controls, 3.27 ±1.28 (pg/ml) versus 29.13 ±9.11 (pg/ml), respectively (p < 0.001). Concerning INH-alpha (rs12720062 G/A) gene polymorphism, GA genotype was significantly less associated with POF in comparison with control group (p = 0.014); the odds ratio was 0.23; the wild homozygous GG genotype revealed significant association with POF, 34 versus 23, respectively (p = 0.007) and the odds ratio was 4.19. Allele G was more significantly associated with POF in comparison with control group; allele A was less
significantly associated with POF in comparison with control group (p = 0.005).
Conclusion: Premature ovarian failure is significantly predisposed by INH-alpha (rs12720062 G/A) genotypes and alleles and it is linked pathogenetically vitamin D deficiency and low serum inhibin level.
References
2. Aramesh, S., Alifarja, T., Jannesar, R., Ghaffari, P., Vanda, R., & Bazarganipour, F. (2021). Does vitamin D supplementation improve ovarian
reserve in women with diminished ovarian reserve and vitamin D deficiency: a before-andafter intervention study. BMC endocrine disorders, 21(1), 126. https://doi.org/10.1186/s12902-021-00786-7
3. Chand, A. L., Harrison, C. A., & Shelling, A. N. (2010). Inhibin and premature ovarian failure. Human reproduction update, 16(1), 39–50. https://doi.org/10.1093/humupd/dmp031
4. Chapman, C., Cree, L., & Shelling, A. N. (2015). The genetics of premature ovarian failure: current perspectives. International journal of women's health, 7, 799–810. https://doi.org/10.2147/IJWH.S64024
5. Christofolini, D. M., Cordts, E. B., SantosPinheiro, F., Kayaki, E. A., Dornas, M. C. F., Santos, M. C., Bianco, B., & Barbosa, C. P.
(2017). How polymorphic markers contribute to genetic diseases in different populations? The study of inhibin A for premature ovarian
insufficiency. Einstein (Sao Paulo, Brazil), 15(3), 269–272. https://doi.org/10.1590/S1679-45082017AO4052
6. Dennis, N. A., Houghton, L. A., Jones, G. T., van Rij, A. M., Morgan, K., & McLennan, I. S. (2012). The level of serum anti-Müllerian
hormone correlates with vitamin D status in men and women but not in boys. The Journal of clinical endocrinology and metabolism, 97(7),
2450–2455. https://doi.org/10.1210/jc.2012-1213
7. Dixit, H., Deendayal, M., & Singh, L. (2004). Mutational analysis of the mature peptide region of inhibin genes in Indian women with ovarian
failure. Human reproduction (Oxford, England), 19(8), 1760–1764. https://doi.org/10.1093/humrep/deh342
8. Dixit, H., Rao, K. L., Padmalatha, V., Kanakavalli, M., Deenadayal, M., Gupta, N., Chakravarty, B. N., & Singh, L. (2006). Expansion of the germline analysis for the INHA gene in Indian women with ovarian failure. Human reproduction (Oxford, England), 21(6), 1643–1644.
https://doi.org/10.1093/humrep/del129
9. Ebrahimi, M., & Akbari Asbagh, F. (2011). Pathogenesis and causes of premature ovarian failure: an update. International journal of fertility & sterility, 5(2), 54–65.
10. Ersoy, E., Ersoy, A. O., Yildirim, G., Buyukkagnici, U., Tokmak, A., & Yilmaz, N. (2016). Vitamin D Levels in Patients with Premature Ovarian Failure. Ginekologia polska, 87(1), 32–36. https://doi.org/10.17772/gp/57839
11. Fallahian, M., Pouresmaeili, F., Azizi, F., Zali, M.R., Samani, E.M., & Kharaziha, P. (2009). Existence of Inhibin α-Subunit Gene Mutation in a Population of Iranian Women with Premature Ovarian Failure. International Journal of Endocrinology & Metabolism, 2, 67-71.
12. Holick M. F. (2007). Vitamin D deficiency. The New England journal of medicine, 357(3), 266–281. https://doi.org/10.1056/NEJMra070553
13. Irani, M., & Merhi, Z. (2014). Role of vitamin D in ovarian physiology and its implication in reproduction: a systematic review. Fertility and
sterility, 102(2), 460–468.e3. https://doi.org/10.1016/j.fertnstert.2014.04.046
14. Jankowska K. (2017). Premature ovarian failure. Menopause review, 16(2), 51–56. https://doi.org/10.5114/pm.2017.68592
15. Kebapcilar, A. G., Kulaksizoglu, M., Kebapcilar, L., Gonen, M. S., Unlü, A., Topcu, A., Demirci, F., & Taner, C. E. (2013). Is there a link between
premature ovarian failure and serum concentrations of vitamin D, zinc, and copper?. Menopause (New York, N.Y.), 20(1), 94–99.
https://doi.org/10.1097/gme.0b013e31826015ca
16. Makanji, Y., Zhu, J., Mishra, R., Holmquist, C., Wong, W. P., Schwartz, N. B., Mayo, K. E., & Woodruff, T. K. (2014). Inhibin at 90: from
discovery to clinical application, a historical review. Endocrine reviews, 35(5), 747–794. https://doi.org/10.1210/er.2014-1003
17. Malloy, P. J., Peng, L., Wang, J., & Feldman, D. (2009). Interaction of the vitamin D receptor with a vitamin D response element in the Mullerian-inhibiting substance (MIS) promoter: regulation of MIS expression by calcitriol in prostate cancer cells. Endocrinology, 150(4), 1580–1587. https://doi.org/10.1210/en.2008-1555
18. Merhi, Z., Doswell, A., Krebs, K., & Cipolla, M. (2014). Vitamin D alters genes involved in follicular development and steroidogenesis in
human cumulus granulosa cells. The Journal of clinical endocrinology and metabolism, 99(6), E1137–E1145. https://doi.org/10.1210/jc.2013-
4161
19. Murdaca, G., Tonacci, A., Negrini, S., Greco, M., Borro, M., Puppo, F., & Gangemi, S. (2019). Emerging role of vitamin D in autoimmune
diseases: An update on evidence and therapeutic implications. Autoimmunity reviews, 18(9), 102350. https://doi.org/10.1016/j.autrev.2019.102350
20. Mutlu, M. F., & Erdem, A. (2012). Evaluation of ovarian reserve in infertile patients. Journal of the Turkish German Gynecological Association, 13(3), 196–203. https://doi.org/10.5152/jtgga.2012.28
21. Panay, N., & Kalu, E. (2009). Management of premature ovarian failure. Best practice & research. Clinical obstetrics & gynaecology, 23(1), 129–140. https://doi.org/10.1016/j.bpobgyn.2008.10.008
22. Savastano, S., Barrea, L., Savanelli, M. C., Nappi, F., Di Somma, C., Orio, F., & Colao, A. (2017). Low vitamin D status and obesity: Role of
nutritionist. Reviews in endocrine & metabolic disorders, 18(2), 215–225. https://doi.org/10.1007/s11154-017-9410-7
23. Sharara, F. I., Scott, R. T., Jr, & Seifer, D. B. (1998). The detection of diminished ovarian reserve in infertile women. American journal of
obstetrics and gynecology, 179(3 Pt 1), 804–812. https://doi.org/10.1016/s0002-9378(98)70087-0
24. Shelling, A. N., Burton, K. A., Chand, A. L., van Ee, C. C., France, J. T., Farquhar, C. M., Milsom, S. R., Love, D. R., Gersak, K., Aittomäki, K., &
Winship, I. M. (2000). Inhibin: a candidate gene for premature ovarian failure. Human reproduction (Oxford, England), 15(12), 2644–2649.
https://doi.org/10.1093/humrep/15.12.2644
25. Wesevich, V., Kellen, A. N., & Pal, L. (2020). Recent advances in understanding primary ovarian insufficiency. F1000Research, 9, F1000 Faculty Rev-1101. https://doi.org/10.12688/f1000research.26423.1
26. Zintzaras E. (2009). Inhibin alpha gene and susceptibility to premature ovarian failure: a data synthesis. Molecular human reproduction, 15(9), 551–555. https://doi.org/10.1093/molehr/gap047
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.